Air Travel & Venous Thromboembolism
Overview
Background & policy context:
The WRIGHT (World Health Organisation Research Into Global Hazards of Travel) is a multi-centred multi-study project investigating the association between travel and venous thrombo-embolism (VTE), a term which covers deep vein thrombosis (DVT) and/or pulmonary embolism (PE).
The project was carried out according to the WRIGHT protocol, and overseen by the Scientific Executive Committee (SEC), consisting of Dr P J Kesteven (chairman), Dr W D Toff, Prof F Paccaud, Prof H R Büller, Prof M Greaves, Dr S Mendis and Prof F.R. Rosendaal.
Objectives:
The WRIGHT project was designed as a series of inter-related studies with the following aims:
- to determine if the risk of venous thrombosis is increased by air travel;
- to determine the magnitude of this risk;
- to determine the effect of other factors on the association;
- to clarify the causal mechanisms.
Methodology:
Furthermore, these studies were performed in several general settings which included clinical endpoints (i.e., symptomatic disease) and surrogate endpoints (i.e., markers of coagulation). The studies were organised into two groups:
1. Epidemiological studies MEGA study:
Data were collected from consecutive patients, aged less than 70 years, presenting to 6 anticoagulation clinics in the Netherlands with a first VTE. Partners served as matched controls. Information was collected by questionnaire on acquired risk factors, and genetic risk factors for VTE were determined on a blood sample. Cases of VTE were verified with hospital records and only objectively diagnosed cases were included in the analysis.
Professional Flyers Study: a retrospective cohort study amongst employees of international companies and organisations. Data concerning occurrence of VTE, risk factors for VTE and habits during air travel were linked to the organisation's travel databases. Exposure was defined as 4 weeks after a 4 hour flight.
Dutch Commercial Pilots Study: A questionnaire was sent to all members of the Dutch Airline Pilots Association who were younger than 55 years on 31 December 2002. Data concerning occurrence of VTE, risk factors for VTE and flight data were included.
2. Patho-physiological studies Chamber Studies:
Forty nine healthy subjects with no known risks of VTE, and a further 24 subjects with mild risk (12 using oral contraception and 12 aged >50 years) were seated in low atmospheric pressure and low oxygen level conditions for 8 hours, simulating flight in a commercial airliner. As a control, the subjects also sat in an identical situation in normal atmospheric pressure and oxygen level. These studies were performed in random order. A large number of haemostatic variables were assessed (involving markers of activation of coagulation, endothelium, platelets and fibrinolysis) before and after these exposures.
Volunteer Study: In a similar study, 71 healthy volunteers flew in a chartered commercial airliner for 8 hours, with the same haemostatic variables assessed before, during and after the flight. Risks factors for venous thrombosis were more abundant in this group: 26 asymptomatic carriers of the factor V Leiden mutation and 30 women using oral contraceptives (15 with, and 15 without the mutation). Two control situations were used - 8 hours watching movies and 8 hours of normal day-to-day activity
Share this page